Allurion Technologies (ALURW) Net Income towards Common Stockholders (2022 - 2026)

Allurion Technologies (ALURW) reported Net Income towards Common Stockholders of -$6.1 million for Q1 2026, down 182.6% on a YoY basis from $7.4 million in Q1 2025, and down 126.48% quarter-over-quarter from $23.0 million in Q4 2025.

Allurion Technologies (ALURW) Net Income towards Common Stockholders (2022 - 2026) Analysis & Trends

Allurion Technologies has reported Net Income towards Common Stockholders for 5 years, with the latest figure at -$6.1 million in Q1 2026.

  • For the quarter ending Q1 2026, Net Income towards Common Stockholders fell 182.6% year-over-year to -$6.1 million; the trailing twelve-month figure through Mar 2026 stood at -$4.3 million (down 136.58% YoY), and the FY2025 full-year result was $347000.0, up 104.82% from the prior year.
  • Net Income towards Common Stockholders for Q1 2026 stood at -$6.1 million, down from $23.0 million in the prior quarter.
  • The five-year high for Net Income towards Common Stockholders was $23.0 million in Q4 2025, with the low at -$22.7 million in Q2 2023.
  • Historically, Net Income towards Common Stockholders has averaged -$7.6 million across 5 years, with a median of -$9.5 million in 2024.
  • Annual changes were most pronounced in 2023 — Net Income towards Common Stockholders sank 270.65% — and 2025, when it surged 339.59%.
  • Allurion Technologies' Net Income towards Common Stockholders stood at -$13.1 million in 2022, then sank by 63.53% to -$21.4 million in 2023, then surged by 55.08% to -$9.6 million in 2024, then jumped by 339.59% to $23.0 million in 2025, then tumbled by 126.48% to -$6.1 million in 2026.
  • The last three Net Income towards Common Stockholders figures came in at -$6.1 million (Q1 2026), $23.0 million (Q4 2025), and -$11.9 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn 1.08 Bn
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn 745.00 Mn
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn 1.15 Bn
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn 1.34 Bn
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn -
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn 411.00 Mn
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 187,319.30
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn 199.50 Mn
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn -
10 Allurion Technologies - - 1.23 Mn -6.10 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -6.10 Mn
Dec 31, 2025 23.02 Mn
Sep 30, 2025 -11.88 Mn
Jun 30, 2025 -9.34 Mn
Mar 31, 2025 7.38 Mn
Dec 31, 2024 -9.61 Mn
Sep 30, 2024 8.74 Mn
Jun 30, 2024 -8.32 Mn
Mar 31, 2024 2.00 Mn
Dec 31, 2023 -21.39 Mn
Sep 30, 2023 -21.89 Mn
Jun 30, 2023 -22.72 Mn
Mar 31, 2023 -18.52 Mn
Dec 31, 2022 -13.08 Mn
Sep 30, 2022 -14.31 Mn
Jun 30, 2022 -6.13 Mn